Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
While effectively inhibiting tumor growth, erlotinib may also cause a range of side effects. These adverse reactions vary from person to person. Most patients may experience mild t···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：98
Erlotinib is a targeted therapeutic agent directed against specific gene mutations, primarily indicated for the treatment of non-small cell lung cancer and advanced pancreatic canc···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：72
Ponatinib is a potent tyrosine kinase inhibitor indicated primarily for the treatment of chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL), esp···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：85
Ponatinib is a prescription medication. Patients must not adjust their dosage or discontinue treatment on their own. All dosage modifications should be made under close supervision···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：82
All medications may be associated with certain adverse reactions, and asciminib is no exception. Most reactions are mild to moderate and manageable, but severe adverse events requi···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：88
The recommended dosage of asciminib should be determined through comprehensive evaluation based on factors including the patient's disease phase (e.g., chronic phase or acceler···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：75
Awareness of these potential side effects helps patients identify them early and take timely intervention measures. However, it should be noted that the assessment and management o···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：64
As a targeted therapeutic agent, the dosage and administration of afatinib should be individually adjusted based on the patient’s specific condition, body surface area and tolerabi···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：78
Anagrelide may cause a range of side effects during treatment, including adverse reactions in the cardiovascular system, digestive system, nervous system, and others. Different pat···【more】
Article source：Captain MedicineRelease date：2026-03-30Recommended：78
During treatment with anagrelide, certain adverse reactions may occur. Depending on patient response and needs, the physician may adjust the dosage of anagrelide. Understanding the···【more】
Article source：Captain MedicineRelease date：2026-03-30Recommended：78
As a targeted therapy, ivosidenib may cause certain side effects while exerting its anti-tumor effects.Less Severe Side EffectsCommon side effects include cracked lips, decreased a···【more】
Article source：Captain MedicineRelease date：2026-03-30Recommended：70
Ivosidenib is a prescription medication. Patients should fully understand the drug information before use. The Ivosidenib Medication Guide covers key aspects such as patient select···【more】
Article source：Captain MedicineRelease date：2026-03-30Recommended：89
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3522025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5522024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3402025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3522025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3272025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3012025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
